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type  II,  thanatophoric  dysplasia  and  achondroplasia  were 
derived following detailed case note review of all perinatal 
lethal skeletal dysplasias (SD) in Northern Ireland over a 12 
year  period.  Multiple  sources  of  ascertainment,  including 
genetic  notes,  radiological  reports  and  post  mortem 
findings, were used. 39 cases were identified. Thanatophoric 
dysplasia was the commonest diagnosis made (22), followed 
by  osteogenesis  imperfecta  type  II  (four  children)  and 















dysplasia  of  the  thoracic  cavity,  leading  to  pulmonary 
















Accurate  figures  on  incidence  and  prevalence  of  lethal 










We  carried  out  a  review  of  all  cases  of  lethal  skeletal 
dysplasias,  defined  as  perinatal  deaths  due  to  skeletal 
Table I
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dysplasias occurring up to 6 months postnatally. The study 






Children,  where  all  regional  and  post-mortem  paediatric 


























A  karyotype  result  was  available  in  20  (51.3%)  babies. 
Karyotype  analysis  failed  in  a  further  nine  (23.1%), 
though three had trisomy 13, 18 and 21 ruled out by FISH 






(Di  George  syndrome)  and  thanatophoric  dysplasia. This 
was the only fetus with thanatophoric dysplasia that had a 
confirmed FGFR3 mutation as this diagnosis is commonly 
















Thanatophoric Dysplasia O.I. Type II Achondroplasia Other Total
46XX 2 1 0 6 9
46XY 6 1 1 1 9
47XX  0 0 1 0 1
Normal, sex not 
reported
1 0 0 0 1
FISH T13/18/21 
normal
3 0 0 0 3
Failed growth 5 0 0 1 6
Not tested 5 2 0 3 10
Table III
Results of other genetic tests
Thanatophoric  Dysplasia O.I. Type II Achondroplasia Other
22q11.2 deletion detected 1 0 0 0
FISH 22q11.2 normal  0 0 0 1
FGFR3 mutation detected 0 0 1 0
PTPN11 normal  0 0 1©  The Ulster Medical Society, 2010.
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abnormalities. One baby did not have radiology; a diagnosis 








22q11.2  deletion  syndrome  and  thanatophoric  dysplasia, 
and  dextroposition  associated  with  possible  Jarcho  Levin 
syndrome.  Hypospadias  and  an  inguinal  hernia  occurred 
in a fetus with possible Pacman dysplasia. Hydrocephalus 
and  cleft  lip  and  palate  were  found  in  a  fetus  with 
thanatophoric dysplasia. These associations were considered 
to be coincidental. One child, who had a normal antenatal 


























our  proportion  of  babies  with  thanatophoric  dysplasia  is 
significantly higher.  













Thanatophoric Dysplasia O.I.  Type II Achondroplasia Other Total






















































95 1649100 23838 23693
96 1661800 24535 24382
97 1671300 24218 24087
98 1677800 23790 23668
99 1679000 23089 22957
00 1682900 21605 21512
01 1698300 22074 21962
02 1696600 21507 21385
03 1702600 21756 21648
04 1710300 22431 22318
05 1724400 22417 22328
06 1741600 23361 23272
Total 20295700 274621 273212
Data from Northern Ireland Statistics & Research Agency ref [www.nisra.
gov.uk]©  The Ulster Medical Society, 2010.
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the  prevalence  rates  previously  published.  Firstly,  almost 




























Prevalence calculations per 10,000 population and total births
Year Thanatophoric Dysplasia O.I. Type II Achondroplasia
No. PTP PTB No. PTP PTB No. PTP PTB
95 0 0 0 0 0 0 0 0 0
96 0 0 0 1 0.006 0.41 0 0 0
97 1 0.006 0.41 1 0.006 0.41 0 0 0
98 3 0.018 1.26 0 0 0 1 0.006 0.42
99 1 0.006 0.43 0 0 0 0 0 0
00 1 0.006 0.46 1 0.006 0.46 0 0 0
01 2 0.012 0.91 1 0.006 0.45 0 0 0
02 2 0.012 0.93 0 0 0 0 0 0
03 3 0.018 1.38 0 0 0 0 0 0
04 3 0.018 1.34 0 0 0 0 0 0
05 2 0.012 0.89 0 0 0 1 0.006 0.45
06 4 0.023 1.71 0 0 0 0 0 0
Total 22 0.011 0.80 4 0.002 0.15 2 0.001 0.073
Key:  PTP = prevalence based on total population, PTB = prevalence based on total number of births
Table VII
Prevalence calculations per 10,000 births
Thanatophoric Dysplasia O.I. type II Achondroplasia
Prevalence range 0 -1.71 0-0.46 0-0.45
Donnelly (this study) 0.80 0.15 0.07
Orioli4 0.09 0.43 0.46




Waller3 - Texas 0.21 0.39©  The Ulster Medical Society, 2010.






date  for  lethal  skeletal  dysplasias.  We  have  shown  that 






fetal  pathologists  at  the  Royal  Belfast  Hospital  for  Sick 
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